SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3/A - Registration statement under Securities Act of 1933: [Amend]
SEC Accession No. 0001193125-16-784007
Filing Date
2016-12-02
Accepted
2016-12-02 17:15:56
Documents
4

Document Format Files

Seq Description Document Type Size
1 S-3/A d293683ds3a.htm S-3/A 58100
2 EX-5.1 d293683dex51.htm EX-5.1 28279
3 GRAPHIC g293683ex51logoa.jpg GRAPHIC 8411
4 GRAPHIC g293683g1202161419649.jpg GRAPHIC 2100
  Complete submission text file 0001193125-16-784007.txt   102151
Mailing Address 10182 TELESIS COURT, 6TH FLOOR SAN DIEGO CA 92121
Business Address 10182 TELESIS COURT, 6TH FLOOR SAN DIEGO CA 92121 858-207-4264
LA JOLLA PHARMACEUTICAL CO (Filer) CIK: 0000920465 (see all company filings)

IRS No.: 330361285 | State of Incorp.: CA | Fiscal Year End: 1231
Type: S-3/A | Act: 33 | File No.: 333-214721 | Film No.: 162031977
SIC: 2836 Biological Products, (No Diagnostic Substances)